Objective To characterise the changing trends in the pharmacological management of SLE in the USA between 2007 and 2023 as ...

SLE: Systemic lupus erythematosus ... this setting are antimalarials and conventional immunosuppressives. Treatment of lupus nephritis Treatment can be divided into an initial phase where ...

Lupus and menopause can interact in complex ways, with menopause sometimes worsening lupus symptoms or, in other cases, ...

Study reveals that achieving low disease activity or remission in lupus patients with high disease activity reduces organ ...

5 “Treating physicians should be aware of the importance ... “However, we know that African American women with SLE have more ...

CD40L inhibitor dapirolizumab pegol significantly reduced disease activity and corticosteroid use in patients with SLE in the PHOENYCS GO trial.

ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.

Sana Biotechnology results from the phase 1 study using SC291 for the treatment of patients with SLE are expected in 2025.

DelveInsight's 'Lupus Nephritis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline lupus ...

The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.